Société Reneo Pharmaceuticals, Inc.
Actions
RPHM
US75974E1038
Recherche biotechnologique et médicale
Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,9 USD | 0,00 % | +17,28 % | +18,75 % |
Métier
Nombre d'employés: 8
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Niall O'Donnell
FOU | Founder | 51 | - |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 09/12/20 |
Michael Grey
FOU | Founder | 71 | 22/09/14 |
Jennifer P. Lam
ADM | Chief Administrative Officer | - | 01/08/21 |
Michael Cruse
COO | Chief Operating Officer | 52 | 01/12/20 |
Chief Tech/Sci/R&D Officer | 64 | 01/01/18 | |
Ashley Hall
PRN | Corporate Officer/Principal | 52 | 11/10/21 |
Corporate Officer/Principal | - | 01/01/18 | |
Wendy Johnson
PRN | Corporate Officer/Principal | 72 | 01/01/17 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Michael Grey
FOU | Founder | 71 | 22/09/14 |
Director/Board Member | 64 | 01/12/17 | |
Paul Hoelscher
BRD | Director/Board Member | 59 | 20/01/22 |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 09/12/20 |
Stacey Seltzer
BRD | Director/Board Member | 47 | 01/12/20 |
Niall O'Donnell
FOU | Founder | 51 | - |
Bali Muralidhar
BRD | Director/Board Member | 44 | 01/04/21 |
Roshawn Blunt
BRD | Director/Board Member | 49 | 01/01/22 |
Eric Dube
BRD | Director/Board Member | 51 | 15/03/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 33 420 808 | 32 392 707 ( 96,92 %) | 0 | 96,92 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+18,75 % | 63,5 M | |
+42,04 % | 54,04 Md | |
+43,57 % | 41,96 Md | |
-1,15 % | 41,92 Md | |
-7,59 % | 28,35 Md | |
+11,98 % | 26,35 Md | |
-22,50 % | 19 Md | |
+8,05 % | 13 Md | |
+28,99 % | 12,28 Md | |
+25,55 % | 12,19 Md |
- Bourse
- Actions
- Action RPHM
- Société Reneo Pharmaceuticals, Inc.